Resilience Care featured prominently this week for expanding the visibility and reach of its telemonitoring platform across Europe and the U.S. The company underscored deployments of its oncology, psychiatry and gastroenterology telemonitoring solutions in more than 200 healthcare facilities, signaling an advanced commercialization phase and a growing reference network.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resilience Care is set to exhibit again at SantExpo 2026 in Paris, where it will focus on hospital organization, care economics and digital transformation through telemonitoring. The firm plans agora sessions with internal leaders and external stakeholders, as well as solution demonstrations with partners including InterSystems, Institut de Cancérologie de l’Ouest, Hoppen, Inicea and SantéAdom.
The company also joined a cross-border policy panel at the French Embassy in Berlin ahead of the DMEA Connecting Digital Health conference, emphasizing patient journeys and telemonitoring in France and Germany. This engagement reinforces its positioning in European policy and innovation circles and may support deeper relationships with providers, payers and regulators focused on real-world evidence and outcome-based care.
In oncology, Resilience Care is promoting Remote Therapeutic Monitoring as a way to capture real-world patient data between visits and improve symptom management at scale. The company highlighted the risks associated with limited visibility between appointments, particularly for community oncology practices, and is positioning its platform to support early warning, structured triage and continuity of care.
The firm plans a targeted presence at the Community Oncology Alliance Conference in Orlando, including Booth 601, and will participate in the 2026 ASCO Annual Meeting in Chicago to engage directly with oncologists and researchers. These conferences are intended to strengthen clinical adoption, align with value-based oncology initiatives and potentially open avenues for research collaborations using real-world data.
Across these initiatives, Resilience Care is aligning its strategy with system-wide priorities such as hospital efficiency, interoperability and better use of health data for care and research. While no financial metrics or contract values were disclosed, the combination of expanding deployments, policy engagement and conference visibility suggests a week of consolidation for its position in digital health and telemonitoring-driven oncology care.